New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 1, 2014
08:46 EDTSRNESorrento Therapeutics receives two NIH small business grants
Sorrento Therapeutics announced that it has received two NIH small business grants which will fund the development of bispecific antibodies for two of its anti-bacterial immunotherapies. Sorrento's highly diverse, fully human G-MAB library and proprietary antibody conjugation technology platforms have broad applications beyond oncology, including other therapeutic areas such as anti-infectives and auto-immune diseases.
News For SRNE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 1, 2015
13:15 EDTSRNESorrento acquires South American rights to Cynviloq
Sorrento Therapeutics announced that its fully owned subsidiary, IGDRASOL, has acquired exclusive distribution rights from Samyang Biopharmaceuticals, a South Korean corporation, to Cynviloq in South America.
April 30, 2015
16:56 EDTSRNESorrento Therapeutics appoints Mark Durand as CFO
Subscribe for More Information
April 19, 2015
15:38 EDTSRNESorrento Therapeutics announces 3 preclinical poster presentations on Cynviloq
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use